Showing 1-2 of 2 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Ambrisentan and Sotagliflozin for Prevention of renal Injury; a Randomized Evaluation (ASPIRE)ASPIRE | University Medical Center Groningen | Hiddo Lambers Heerspink | Improving Lives | 01-October-2023 to 30-September-2026 | $1,183,690.64 |
| Integrative Biomarker Modeling to Predict Cardiovascular Drug Efficacy in Type 1 diabetes | University Medical Center Groningen | Hiddo Lambers Heerspink | Improving Lives | 01-July-2026 to 30-June-2029 | $769,690.00 |